HOSPITAL PHARMACY TEAM OF THE YEAR
WESTERN GENERAL HOSPITAL SETTING THE GOLD STANDARD IN HOSPITAL CARE COMMITMENT
T
he Gastroenterology and Rheumatology Pharmacy Team at Western General Hospital, NHS Lothian, have redefined the
role of hospital pharmacy in modern patient care. Recognised for their innovation and multidisciplinary leadership, the team stands out as a model of excellence in specialist care.
Described as visionary, dynamic and integral to the successful delivery of novel and complex therapies, the team has pioneered numerous clinical and operational advancements in the past year. From championing biosimilar switching to expanding pharmacist-led clinics, their work has combined cutting-edge practice with a human centred ethos to make a measurable impact across the hospital and wider health board.
One of the team’s most high-profile achievements has been their leadership in the biosimilar switch programme for high-cost biologics such as ustekinumab and tocilizumab. These switches have delivered significant efficiency savings while
18
scottishpharmacist.com
maintaining the gold standard of care, an essential achievement during a time of continuing financial strain. Patients were engaged from the outset, provided with clear information and supported via helplines, ensuring a smooth and safe transition with no compromise to outcomes.
At the heart of their success is a bold approach to pharmacist-led service delivery. This includes the development of post-induction review clinics and Virtual Biologic Clinics (VBCs), where pharmacists take an active role in assessing patient responses to treatment. Through clinical examination skills and a collaborative approach with consultants, they help adjust dosages, switch therapies where necessary and optimise patient care. These innovations have reduced treatment waiting times from eight weeks to just three, unlocking vital capacity for consultants to focus on more complex patients.
Beyond direct clinical care, the team has developed treatment pathways for inflammatory
bowel disease and rheumatic conditions, now used throughout the southeast region.
A key element of their impact lies in their interdisciplinary collaboration. Whether it is working closely with consultants to streamline biosimilar implementation or partnering with procurement to ensure efficient medicine supply chains, the team plays a central role in coordinating care. Their work on Homecare services has improved patient access and compliance by allowing delivery of specialist medicines directly to patients, reducing the burden on hospital visits and enhancing quality of life. The team’s influence extends well beyond their own walls. Their work is shared nationally, with team members taking on leadership roles, chairing professional groups and presenting at conferences. Their expertise in managing biologics is widely sought after and they are actively shaping the direction of pharmacy services across NHS Scotland.
At the core of their success is a commitment to continuous learning and professional development. Pharmacists within the team are
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
